Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Radiotherapy and Androgen Deprivation Therapy Versus Androgen Deprivation Therapy Alone After Prostatectomy for Node Positive Prostate Cancer (RADVAN): A Multicenter, Randomized Controlled Phase Ⅲ Trial

NCT07477626 is registered in ClinicalTrials.gov with Sun Yat-sen University as lead sponsor.

NCT NCT07477626
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07477626 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Radiotherapy and Androgen Deprivation Therapy Versus Androgen Deprivation Therapy Alone After Prostatectomy for Node Positive Prostate Cancer (RADVAN): A Multicenter, Randomized Controlled Phase Ⅲ Trial
Lead sponsor
Sun Yat-sen University
Phase
Phase 3
Overall status
Recruiting
Start date
March 20, 2026
Completion date
December 31, 2038
Enrollment
372 (estimated)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

androgen deprivation therapy, lymph node positive, prostate cancer (post prostatectomy), prostate cancer non-metastatic, radiotherapy; image-guided